AKT1 and melanoma: Since the PTEN/PI3K/AKT signaling pathway plays a key role in cell proliferation, growth, and apoptosis [60], we speculated whether these enhancers could affect tumor viability or drug response via the PI3K/AKT signaling pathway in melanoma cells.